Sales & Marketing Sponsored Planning, Executing, and Monitoring: The Three Pillars of an... No longer are physicians the sole concern for the life sciences’ sales and marketing function.
Views & Analysis Tunnah’s musings: Rare diseases hold key to future of drug d... The lessons that can be learned for the future of drug development from the collaboration and innovation in this space.
Views & Analysis Who needs (early) advice? You do! The prospects for HTA Early Scientific Advice programmes.
Views & Analysis Patient-centricity and pharma: where are we now? How should the industry define patient-centricity, and how should progress be measured?
Views & Analysis Every voice matters: demand assessment in rare diseases A market research approach suitable for the complexities found in rare diseases.
News CMS aims for broader GLP-1 access via federal programmes CMS has revealed a new, voluntary access programme that aims to broaden the use of GLP-1 agonist medicines for diabetes and obesity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
